Show results for
Refine by
Vaccine Development Suppliers Serving Italy
70 companies found
based inUpton-Upon-Severn, UNITED KINGDOM
Established in 1979, Bio-Diagnostics is privately owned, rapidly growing, UK bio-tech business, based 40 miles south west of Birmingham, UK. Bio-Diagnostics is highly regarded and trusted globally, working closely with partners providing, ...
based inWertheim, GERMANY
The new Walter Graf u. Co. began manufacturing injection syringes made of glass. The demand for all glass syringes, a new technology based on the old “Record Syringe” was huge at the time. Over time machines and tools were developed resulting in ...
Our range of single-use syringes has not only been extended by the sizes 30 and 50 ml, but also by the new packaging units Bulk and ...
based inShanghai, CHINA
Bio-Link is a high-tech group enterprise that provides process solutions for the life science industry. We focus on the R&D and manufacturing of equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell ...
Innovative design of RNase-free bioprocess disposable bags with 100% RNase/DNase inspection and release of products and customer ...
based inLangenfeld, GERMANY
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ...
based inBilthoven, NETHERLANDS
Bilthoven Biologicals produces various products such as polio, diphtheria tetanus polio combination vaccine (DT-IPV), tetanus vaccines and BCG for the treatment of bladder cancer. At BBio we are working on developing vaccines that give our world ...
BCG (Bacillus Calmette-Guérin) is known as a vaccine against tuberculosis. But BCG is also an effective medication used in the treatment of bladder cancer. Bilthoven Biologicals produces BCG for a third party as treatment against bladder ...
based inRixensart, BELGIUM
CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a ...
based inRedwood City, CALIFORNIA (USA)
Meissa Vaccines was founded with a mission to protect people everywhere from deadly respiratory viruses and a commitment to develop innovative technologies capable of delivering effective vaccines at a global scale. Meissa is developing live ...
Respiratory viruses are one of the biggest threats to human health. Vaccines are the most effective healthcare tool to combat infectious diseases and have saved more lives than any other type of medicine. Meissa is dedicated to ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
based inElkridge, MARYLAND (USA)
Latham BioPharm Group (LBG) is a leading life sciences consulting company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies alike to solve complex business, regulatory, and product development ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inSan Jose, CALIFORNIA (USA)
Precigenome LLC is located in the heart of Silicon Valley, San Jose, California, USA. We have been focusing on developing nanoparticle synthesis systems and solutions for preparation of lipid nanoparticles, liposomes, & PLGA nanoparticles. We also ...
NanoGenerator™ Flex-S Plus is a high-performance formulation screening platform for nanoparticles synthesis such as lipid nanoparticles(LNP), liposomes, PLGA, etc. Especially, it is the screening platform with high-throughput up to 48-96 ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major ...
based inVienna, AUSTRIA
Nuvonis is a biotech company based in Vienna, Austria, providing innovative Cell Banks and technical support for vaccine development. The Nuvonis team is highly experienced in all aspects of vaccine production, both in small biotech companies up to ...
The generation of high titer vaccines with acceptable purity is a challenging task, both regarding upstream and downstream steps. Upstream development uses well established technologies such as bioreactors (e.g., ...
based inCambridge, MASSACHUSETTS (USA)
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP ...
based inDuisburg, GERMANY
Genekam Biotechnology AG was found in 1999. It started offering DNA-Tests in 2001. From 2004, it started development of PCR kits while exporting to 5 countries, today (2015) it exports to 70 countries in the world. Genekam covers different targets ...
based inMonthey, SWITZERLAND
We are a Swiss biologics CDMO (contract development and manufacturing organization) specializing in challenging protein expression services and based in Monthey, Switzerland. The heart of ExcellGene is applying smart science and technology to ...
We've created a stable, clonally derived, recombinant, suspension grown CHO cell line that produces a secreted, stabilized version of the trimeric spike protein of ...
based inPeachtree Corners, GEORGIA (US) (USA)
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in ...
The Cytotoxic T-Lymphocyte Associated Protein 4 (CTLA4) Epitope Mapping Peptide Array is a semi-quantitative array displaying 177 synthesized peptides representing the full-length CTLA4. It is suitable for antibody epitope mapping and detection of ...
based inEmeryville, CALIFORNIA (USA)
Nutcracker Therapeutics is an early-stage company that is pioneering a revolutionary therapeutic development and manufacturing platform designed to enable the advancement of RNA-based treatments for as many diseases as possible, as fast as possible. ...
RNA is often seen as a molecule with a supporting role in human physiology– a go-between for DNA and proteins. In fact, RNA is a macromolecule with immense versatility, which can be harnessed to tackle the most complex and difficult to treat ...
based inSolna, SWEDEN
We are developing the first vaccine for protection against diarrhoea caused by ETEC in travellers, military, health care personnel and endemic populations with a key focus on the most vulnerable – children under five years of age in Low- and ...
Our development is mainly focused on developing the first vaccine in the world against Enterotoxigenic Escherichia Coli (ETEC) induced diarrhoea. Our vision is to develop an ETEC ...